Effect of Starter Formula on Infection Prevention
Effect of Starter Formula on Infection Prevention
The aim of this trial is to test the efficacy of an infant formula containing synbiotics on
 the prevention of gastro-intestinal infections.
Inclusion Criteria:

 -  Healthy newborn infant

 -  Full term infant (≥ 37 weeks gestation; ≤ 42 weeks gestation)

 -  Age of infant is ≤ 13 days at the time of enrollment

 -  Birth weight ≥ 2500g and ≤ 4500g

 -  For the FF groups: The infant's mother has elected not to breastfeed

 -  For the BF group: The infant's mother has elected to fully breastfeed her baby, from
 enrollment to at least 3 months of age

 -  Having obtained his/her legal representative's informed consent

 Exclusion Criteria:

 -  Congenital illness or malformation that may affect normal growth (especially
 immunodeficiencies)

 -  Significant pre-natal and/or post-natal diseases

 -  Perinatal antibiotic or infants on antibiotics at the time of inclusion

 -  Infants whose mother has had an acute infection during the last month of pregnancy

 -  Re-hospitalisation for more than 2 days in the first 14 days of life (exceptionally,
 infants re-hospitalized because of jaundice may be enrolled in the study)

 -  Receiving infant formula containing probiotics and/or prebiotics at the time of
 enrollment

 -  Newborn whose parents / caregivers cannot be expected to comply with treatment

 -  Newborn currently participating in another interventional clinical trial